Synermore
Taipei
About Synermore
Synermore is a Taiwan based biotech company focused on the research and development of innovative and biosimilar monoclonal antibodies in the areas of oncology, infectious diseases, and immune disorders. The core competence is to bring products from research stage through IND-enabling nonclinical and CMC activities to clinical stage of development.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: M&A
- Last round: Corporate Round (Apr 2024)
- Website: synermore.com
- Phone: +886 2 2659 0988
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/synermore-1607744 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.